1-31577285-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022164.3(TINAGL1):c.137G>A(p.Arg46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,612,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R46W) has been classified as Uncertain significance.
Frequency
Consequence
NM_022164.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TINAGL1 | NM_022164.3 | c.137G>A | p.Arg46Gln | missense_variant | 2/12 | ENST00000271064.12 | NP_071447.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TINAGL1 | ENST00000271064.12 | c.137G>A | p.Arg46Gln | missense_variant | 2/12 | 1 | NM_022164.3 | ENSP00000271064.7 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000689 AC: 17AN: 246764Hom.: 0 AF XY: 0.0000522 AC XY: 7AN XY: 134016
GnomAD4 exome AF: 0.0000425 AC: 62AN: 1460416Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726556
GnomAD4 genome AF: 0.000151 AC: 23AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.137G>A (p.R46Q) alteration is located in exon 2 (coding exon 1) of the TINAGL1 gene. This alteration results from a G to A substitution at nucleotide position 137, causing the arginine (R) at amino acid position 46 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at